The CEO of gene therapy company CombiGene, Jan Nilsson, has been appointed Chairman of CCRM Nordic, Centre for Commercialization of Regenerative Medicine. This national industrial cluster also includes companies such as AstraZeneca, Cytiva, Getinge, Takara Bio Europe, TATAA Biocenter and Verigraft with support from Vinnova, GoCo Health Innovation City and GU Ventures. The goal is to accelerate the investment in advanced medicinaltherapies and contribute to making Sweden a world leader in this field by 2030.